New Pill Combo Approved For Breast Cancer That Stops Responding To Hormone Therapy

Wilserdly is for advanced cancers with a gene change that helps tumors resist standard hormone treatment
Homepage of the U.S. Food and Drug Administration (FDA) is seen on the screen of a computer.
Dongyu Xu/Adobe Stock
Published on: 
Updated on: 
Loading content, please wait...